According to ResMed's latest financial reports the company's current EPS (TTM) is HK$47.77. In 2022 the company made an earnings per share (EPS) of HK$42.81 an increase over its 2021 EPS that were of HK$27.76.
Year | EPS | Change |
---|---|---|
2023 (TTM) | HK$48.25 | 12.72% |
2022 | HK$42.81 | 54.19% |
2021 | HK$27.76 | -25.88% |
2020 | HK$37.46 | 52.37% |
2019 | HK$24.58 | 0.63% |
2018 | HK$24.43 | 55.94% |
2017 | HK$15.67 | -12.17% |
2016 | HK$17.84 | -7.63% |
2015 | HK$19.31 | -0.4% |
2014 | HK$19.39 | 9.65% |
2013 | HK$17.68 | 12.32% |
2012 | HK$15.74 | -10.18% |
2011 | HK$17.53 | 58.6% |
2010 | HK$11.05 | 23.91% |
2009 | HK$8.92 | 44.65% |
2008 | HK$6.17 | 96.3% |
2007 | HK$3.14 | -41.3% |
2006 | HK$5.35 | 35.29% |
2005 | HK$3.96 | 9.68% |
2004 | HK$3.61 | 20% |
2003 | HK$3.01 | 27.05% |
2002 | HK$2.37 | 159.57% |
2001 | HK$0.91 | -43.37% |
2000 | HK$1.61 | 25.76% |
1999 | HK$1.28 | 45.05% |
1998 | HK$0.88 | 54.24% |
1997 | HK$0.57 | 28.26% |
1996 | HK$0.45 |